LongBio Pharma (HKG:1779) said its shares have been included in the eligible securities lists for Southbound Trading under the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, effective Monday, according to a same-day Hong Kong bourse filing.
The inclusion gives eligible mainland Chinese investors direct access to trade LongBio Pharma shares through the two Stock Connect programs.